Upload
sophia-reese
View
214
Download
0
Tags:
Embed Size (px)
Citation preview
Product Safety Governance
Philippe Martin, MBA, DEA, MS, PhDEuropean Commission
Directorate General for Health and Consumersphilippe.martin (at) ec.europa.eu
http://ec.europa.eu/health/index_en.htm#
Risk Governance of Manufactured Nanoparticles Brussels, 21 Nov 2011, 13.30 – 18.00
Outline• Nano risk governance• Products, claims, and regulation• The definition and what it means• What risk managers learn from risk
assessors
FP6 & FP7 safety research2004 “Mapping Nano Risks”SCENHIRSCCSEFSAEMA
IRG
C (
200
7,
Fig.
1,
p.
23;
ww
w.irg
c.org
)
IRG
C (
200
7,
Fig.
1,
p.
23;
ww
w.irg
c.org
)
Nano Safety for Success DialoguesPublic consultationsFP7 projects
2008 Review2nd (forthcoming) reviewInventoryJRC databaseDefinitionInt’l Regulators’ MeetingsTransatlantic Economic Council
IRG
C (
200
7,
Fig.
1,
p.
23;
ww
w.irg
c.org
)
Products, claims, and regulation
Substances (= REACH)
Consumer Products
Cosmetics
Food and feed
Medicines & Medical Devices
The definition and what it means
1 nm < < 100 nm 100 nm < < <
What risk managers learn from risk assessors
Exposure
Detection: Size, mass, contrast
Ag
NP
s in
mea
t: C
ourt
esy
Q.
Cha
udur
y
Hay
stac
k in
Buh
tan:
Flic
ker/
Cop
yrig
ht f
ree
Hazard
Risk assessment
Conclusion• Nano innovation potential
confirmed• Product safety framework in place• Guidelines to make it happen• No “sub-prime” risk assessment• S&T challenges to be addressed• Governance & engagement as key